Alterity Therapeutics Limited (ATHE)
Nasdaq: ATHE · Pharmaceutical Preparations · Melbourne, AU · filing with the SEC since 2002
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 202623 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Alterity Therapeutics Limited’s names, not what it holds today.
Patents granted
23
23 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against none in 2024 and 1 in 2023
Applications published
21
since 2001, to Dec 31, 2025
Names they are printed under
4
a former name, its own name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals3
Organic fine chemistry2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
Prana Biotechnology Limited a former name
AU, as the owner printed on each patent
16 published
Alterity Therapeutics Limited its own name
AU, as the owner printed on each patent
0 published
Prana Biotechnology Limited a former name
named as the applicant on its applications, in AU
3 published
Alterity Therapeutics Limited its own name
named as the applicant on its applications, in AU
2 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Mar 14, 2023 | 11,603,364 | Acyl hydrazone derivative compounds for treating disease | Organic fine chemistry | Alterity Therapeutics Limited |
| Jun 14, 2022 | 11,357,770 | Method of treating immunoglobulin light chain amyloidosis | Pharmaceuticals | Alterity Therapeutics Limited |
| Oct 26, 2021 | 11,155,547 | Compounds for and methods of treating diseases | Pharmaceuticals | Alterity Therapeutics Limited |
| May 18, 2021 | 11,008,319 | 4H-pyrido[1,2-a]pyrimidin-4-one compounds | Organic fine chemistry | Prana Biotechnology Limited |
| Mar 9, 2021 | 10,941,143 | Imidazo [1,5-a]pyridine compounds and their use | Pharmaceuticals | Alterity Therapeutics Limited |
| Aug 11, 2020 | 10,738,050 | 4H-pyrido[1,2-A]pyrimidin-4-one compounds | Organic fine chemistry | Prana Biotechnology Limited |
| May 14, 2019 | 10,287,285 | 4H-pyrido[1,2-A]pyrimidin-4-one compounds | Organic fine chemistry | Prana Biotechnology Limited |
| Apr 5, 2016 | 9,302,993 | 8-hydroxy quinoline derivatives | Pharmaceuticals | Prana Biotechnology Limited |
| Oct 27, 2015 | 9,169,211 | 8-hydroxy quinoline derivatives | Pharmaceuticals | Prana Biotechnology Limited |
| Oct 20, 2015 | 9,163,018 | Method of treatment of age-related macular degeneration (AMD) | Pharmaceuticals | Prana Biotechnology Limited |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Mar 3, 2022 | 2022/0064142 | COMPOUNDS FOR AND METHODS OF TREATING DISEASES | Organic fine chemistry | Alterity Therapeutics Limited · patent 11,603,364 granted from it |
| Jul 29, 2021 | 2021/0230159 | 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS | Organic fine chemistry | Prana Biotechnology Limited |
| Oct 8, 2020 | 2020/0317670 | 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS | Organic fine chemistry | Prana Biotechnology Limited · patent 11,008,319 granted from it |
| Sep 17, 2020 | 2020/0291021 | COMPOUNDS FOR AND METHODS OF TREATING DISEASES | Pharmaceuticals | Alterity Therapeutics Limited · patent 10,941,143 granted from it |
| Nov 21, 2019 | 2019/0352301 | 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS | Organic fine chemistry | Prana Biotechnology Limited · patent 10,738,050 granted from it |
| Nov 14, 2019 | 2019/0343825 | Method of Treating Immunoglobulin Light Chain Amyloidosis | Pharmaceuticals | Prana Biotechnology Limited · patent 11,357,770 granted from it |
| Sep 21, 2017 | 2017/0267676 | 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS | Organic fine chemistry | Prana Biotechnology Limited · patent 10,287,285 granted from it |
| Dec 17, 2015 | 2015/0359796 | QUINAZOLINONE COMPOUNDS | Pharmaceuticals | Prana Biotechnology Limited |
| Nov 26, 2015 | 2015/0335635 | 8-HYDROXY QUINOLINE DERIVATIVES | Pharmaceuticals | Prana Biotechnology Limited |
| Apr 2, 2015 | 2015/0094334 | 8-HYDROXY QUINOLINE DERIVATIVES | Pharmaceuticals | Prana Biotechnology Limited · patent 9,169,211 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.